Jesus M. Matos, M.D.

Joined Peripheral Vascular Associates in 2015

General Information

  • Joined Peripheral Vascular Associates in 2015
  • Undergraduate: The University of Texas at Austin
  • Doctor of Medicine: Indiana University School of Medicine
  • General Surgery Residency: Indiana University School of Medicine
  • Vascular Surgery Fellowship, Baylor College of Medicine 2012 – 2014

Board Certified

  • American Board of Surgery, Vascular Surgery 2015
  • Registered Physician in Vascular Interpretation 2014
  • American Board of Surgery, General Surgery 2012
  • Fundamentals of Laparoscopic Surgery Certification 2012

Societies and Organizations

  • Society for Vascular Surgeons 2017
  • Southern Association for Vascular Surgery candidate member 2014
  • Society for Clinical Vascular Surgery 2014
  • Peripheral Vascular Surgery Society 2013
  • American College of Surgeons 2005

Honors and Awards

  • Southern Society for Vascular Surgeons 38th Annual Meeting (January 17, 2014)
  • First place on poster presentation
  • Plenary presentation at The Society for Vascular Surgery Annual Meeting, San Francisco, CA (May 31st 2013)
  • Association of Program Directors in Vascular Surgery Executive Council Member, 2013-2014
  • General Surgery Administrative Chief (2011-2012)
  • Indiana University ACGME Resident Council Representative (2011-2012)
  • Plenary presentation at The Society for Vascular Surgery Annual Meeting, Chicago, IL (June 16th 2011)
  • The Carl H. McCaskey Research Award
  • American College of Surgeons Indiana Chapter 2008
  • NIH NRSA T32 Cancer Biology Training Research Fellowship, 2007 – 2009
  • Indiana University School of Medicine Senior Honors Program in Surgery, 2005


Book Chapters
  • Lin PH, Poi MJ, Matos JM, Kougias P, Bechara C and Chen C. Arterial Disease. In: Brunicardi FC, Anderson DK, Billard TR, Dunn DL, Hunter JG, Pollock RE (editors). Schwartz’s Principles of Surgery, 9th ed., McGraw-Hill Inc. New York, NY. 2013
  1. Outcomes following operative management of thoracic outlet syndrome in the pediatric patients.  Matos JM, Gonzalez L, Kfoury E, Echeverria A, Bechara CF, Lin PH.  Vascular 2018 Epub
  2. Thromboembolic Risk of Endovascular Interventions for Lower Extremity Deep Venous Thrombosis.  Lidsey P, Echeverria A, Poi MJ, Matos JM, Bechara CF, Cheung M, Lin PH.  Ann Vasc Surg.  2017 Nov;S0890-5096(17)
  3. Long-Term outcomes of staged basilica vein transposition for hemodialysis access in children.  Kfoury E, Demaree CJ, Poi MJ, Matos JM, Bechara CF, Lin PH.  J Vasc Access. 2017 Sep 11;18(5):366-370.
  4. Long-Term outcomes of Single-Port Laparoscopic Placement of Peritoneal Dialysis Catheter.  Pan A, Poi MJ, Matos JM, Jiang JS, Kfoury E, Echeverria A, Bechara CF, Lin PH. Vasc Endovascular Surg. 2016 Jul;50(5):343-8
  5. Treatment outcomes and lessons learned from trans illuminated powered phlebectomy for varicose veins in 1034 patients.  Lin PH, Matos JM, Chen A, Kim W, Poi MJ, Jiang JS, Bechara CF. Vasc Endovascular Surg. 2016 May;50(4):277-82
  6. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.  Waters JA, Matos JM, Yip-Schneider M, Aguilar-Saavedra JR, Crean CB, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.  Surgery 2015 Oct;158(4):881-8
  7. Totally Percutaneous EVAR: 30-Day Results From the Independent Access Site Closure Study of the PEVAR Trial – ProGlide vs. SEVAR.  Matos, JM, Krajcer Z.  Tex Heart Inst J. 2013;40(5):560-1
  8. Validating Common Carotid Artery Stenosis by duplex ultrasound with carotid angiogram or computed tomographic angiography scan.  Matos JM, Barshes NR, Pisimisis G, Lin PH, Kougias P, Bechara CF. J Vasc Surg. 2014 Feb;59(2):435-9
  9. Aortopulmonary Fistula after type III Aortic Dissection. Matos JM, de la Cruz KI, Ouzounian M, Preventza O, LeMaire SA, Coselli JS. Tex Heart Inst J. 2014 Apr 1;41(2):198-202
  10. Management of the Acutely Ischemic Limb in the Infant Population: Evidence for Non-Operative Management.  Matos JM, Fajardo A, Dalsing MC, Motaganahalli RL, Akingba GA, Lemmon GW, Murphy MP. Journal of vascular surgery. 2011 November 30.
  11. Alcohol Induces Liver Neoplasia in a Novel Alcohol-Preferring Rat Model. Yip-Schneider MT, Doyle CJ, McKillop IH, Wentz SC, Brandon-Warner E, Matos JM, Sandrasegaran K, Saxena R, Hennig ME, Wu H, Waters JA, Klein PJ, Froehlich JC, Max  Schmidt C.  Alcohol Clin Exp Res. 2011 Jul 25.
  12. Pancreatic surgery evolution at a high-volume center.  Ziegler KM, Nakeeb A, Pitt HA, Schmidt CM, Bishop SN, Moreno J, Matos JM, Zyromski NJ, House MG, Madura JA, Howard TJ, Lillemoe KD.  Surgery. 2010 Oct;148(4):702-9; discussion 709-10.
  13. Solid pseudopapillary neoplasms of the pancreas: A multi-institutional study of 21 patients. Matos JM, Grützmann R, Agaram NP, Saeger HD, Kumar HR, Lillemoe KD, Schmidt CM.   Journal of Surgical Research. 157(1):e137-42, 2009 Nov.
  14. Pancreatic Acinar Cell Carcinoma:  A Multi-institutional Study.  Matos JM, Schmidt CM, Turrini O, Agaram NP, Niedergethmann M, Saeger HD, Merchant N, Johnson CS, Lillemoe KD, Grützmann R.  J Gastrointest Surg. 2009 Jun 3,
  15. A Pilot Study of Proteomic Profiles of Human Hepatocellular Carcinoma in the United States.Matos JM, Witzmann FA, Cummings OW, Schmidt CM.  Journal of Surgical Research, 2009  155(2):237-43, 2009 Aug
  16. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.  Hennig M, Yip-Schneider MT, Klein P, Wentz S, Matos JM, Doyle C, Choi J, Wu H, O’Mara A, Menze A, Noble S, McKillop IH, Schmidt CM.  J Surg Res. 2009 Jun 15;154(2):187-95.
  17. Very High Serum CA 19-9 Levels: A contraindication to Pancreaticoduodenectomy? Turrini O, Schmidt CM, Moreno J, Parikh P, Matos JM, House MG, Zyromski NJ, Nakeeb A, Pitt HA, Lillemoe KD.  J Gastrointest Surg. 13(10):1791-7, 2009 Oct.
  18. Adjuvant Chemoradiaton Therapy for Pancreatic Adenocarcinoma: Who Really Benefits? Merchant NB, Rymer J, Koehler EA, Ayers GD, Castellanos J, Kooby DA, Weber SH, Cho CS, Schmidt CM, Nakeeb A, Matos JM, Scoggins CR, Martin RC, Kim HJ, Ahmad SA,  Chu CK, McClaine R, Bednarski BK, Staley CA, Sharp K, Parikh AA.  J Am Coll Surg. 2009 May;208(5):829-38.
  19. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma.  Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD, Bilimoria KY.  J Gastrointest Surg. 2008 Dec;12(12):2078-86.
  20. A Pilot Study of Perillyl Alcohol in Pancreatic Cancer.  Matos JM, Schmidt CM, Howard, TJ, Cummings OW, Wiebke EA, Madura JA, Loehrer PJ, Crowell PL.  Journal of Surgical Research, Feb 2008, volume 31(2): 309.
  21. Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies.  Holcomb B, Yip-Schneider M, Matos JM, Dixon J, Kennard J, Mahomed J, Shanmugam R, Sebolt-Leopold J, Schmidt CM.  Journal of Gastrointestinal Surgery, February 2008, volume 12(2):v288-96.
  22. Novel Model of alcohol-induced Hepatocellular Carcinoma (HCC).  Matos JM, Klein PJ, Wentz SC, Hennig ME, Yip-Schneider MT, Froehlich JC, Schmidt CM.  Alcoholism clinical and experimental research, June 2007, volume 31(6): 34A.
  • Contact Us Today: (210) 237-4444
  • Veintec: (210) 483-8822